Tag: investment
-
Novo Nordisk to Add New Diabetes R&D Center in Seattle
The Danish drug maker Novo Nordisk says it will add a new research facility to study type 1 diabetes in Seattle, Washington. The lab is expected to open this summer and employ 20 researchers on the site of its current inflammation research center. Novo Nordisk says the new lab will conduct translational studies that combine…
-
U.S. VC Investments Up for 2011, Flat for Science Companies
Venture capital (VC) investors in the U.S. increased in 2011 compared to 2010, both in terms of numbers of deals and amount of money invested. However, the fourth quarter of the year was an unusually slow period, according to Dow Jones VentureSource that compiled the data, and consumer Web companies appeared to benefit from the…
-
Report: Asia Closing Gap in U.S. R&D Leadership
National Science Foundation’s new report on global research and development (R&D) trends, Science and Engineering Indicators 2012, shows in the last decade, U.S. leadership in research and development has come under severe challenge from China and other countries in Asia. The report from NSF’s policy-making body, the National Science Board, shows between 1999 and 2009,…
-
Biofuels Developer Secures $17M Investment Round
SG Biofuels Inc., a bioenergy crop company in San Diego, has completed a $17 million financing round to expand its R&D and commercialization programs. The series B funding — the second round of financing after start-up — was lead by life sciences venture capital company Thomas, McNerney & Partners, with participation from Finistere Ventures and…
-
Sanofi, VCs Back Start-Up Deriving Natural Product Drugs
The French drug maker Sanofi, with American venture capital (VC) companies Third Rock Ventures and Greylock Partners, are investing up to $125 million in Warp Drive Bio a new biotechnology company in Cambridge, Massachusetts. Warp Drive Bio, being incubated at Third Rock Ventures, specializes in using genomics to derive drug candidates from natural sources, such…
-
$600M Venture Fund Targets Technology, Health Care Sectors
Canaan Partners, a venture capital company in Menlo Park, California says it has closed contributions to a new fund to finance start-ups in the technology and health care fields. The company says the $600 million fund, the ninth such fund in its series, will support new technology and health care entrepreneurs. Canaan Partners says two-thirds…
-
Diagnostics Company Out-Licenses Cancer Testing Technology
Health Discovery Corporation in Savannah, Georgia says it has licensed its diagnostics technology to NeoGenomics Inc. in Fort Myers, Florida to develop lab tests for blood and solid tumor cancers. The license excludes tests for breast and retina cancers, for which other companies have already acquired Health Discovery’s technology. NeoGenomics will pay Health Discovery Corporation…
-
Report Outlines U.S. Competitive, Innovation Roadmap
The U.S. Department of Commerce released today a report to Congress on “The Competitiveness and Innovative Capacity of the United States” called for by the America COMPETES Reauthorization Act of 2010. Secretary of Commerce John Bryson (pictured left) discussed the report’s main findings in a briefing at the progressive think tank Center for American Progress…
-
Cleantech Investment Volume Up, Deal Numbers Down in 2011
Global investment dollars in clean technologies increased in 2011 from the previous year, but the number investment deals declined somewhat, according to the industry research company CleanTech Group in San Francisco. Clean technologies, as defined by Cleantech Group, include renewable energy sources such as wind and solar, as well as energy efficiency, pollution control, infrastructure…
-
Ophthalmology Drug Delivery Start-Up Gets $4M Investment
An Atlanta-based start-up, Clearside Biomedical, has received a $4 million venture capital investment from Hatteras Venture Partners in Research Triangle Park, North Carolina. Clearside Medical is commercializing technology developed at Emory University and Georgia Tech that delivers drugs to precise locations in the eye using hollow microneedles. Research behind the Clearside Biomedical technology was conducted…